Neuravi Limited
USPTO PatentsView assignee record - 109 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Neuravi ranks #3,402 of 49,997 tracked US assignees by granted-patent volume, with 109 patents across 7 technology areas.
- #3,402
- of 49,997 US assignees by volume
- Top 15%
- by Innovation Score (49.3/100)
- 16.3
- avg claims per patent
- +248%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3402 · Foreign Corporation #3,402 · 109 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MID 109 grants
- TOP-DECILE #3,402/49,997
- PHOTO-FINISH I M A Industria…
- CPC-NARROW A61B · 7 areas
- INNOV-PAR 49.3/100
- CLAIMS-RICH 16.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +248% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: I.M.A. Industria Macchine Automatiche S.P.A. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Neuravi’s 49.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Neuravi
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- 23andMe · near
23andMe · near
49 score
- Alps Electric · near
Alps Electric · near
49 score
- National University… · near
National University… · near
49 score
- Neuravi · this assignee
Neuravi · this assignee
49 score
- Newport Fab · near
Newport Fab · near
49 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Neuravi's Innovation Score is 49.3/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Neuravi?
Each dot is one of Neuravi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neuravi’s own 16.3 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Neuravi's grants concentrate
Neuravi Limited is a focused PatentsView assignee: 7 CPC subclasses with 97.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (32 grants) versus a trough of 2 in 2017. By volume, Neuravi sits between I.M.A. Industria Macchine Automatiche S.P.A. and Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences.
Neuravi's three-year grant acceleration
From 2019–2021 to 2022–2024, Neuravi Limited moved from 30 to 63 grants (2.10x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #188. See the growth leaderboard.
Who files at Neuravi's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- I M A Industria M…
I.M.A. Industria Macchine Automatiche S.P.A.
109 patents
- Ionq
IonQ, Inc.
109 patents
- Kerr Machine
Kerr Machine Co.
109 patents
- Mr Bar-b-q Produc…
Mr. Bar-B-Q Products LLC
109 patents
- Nucor
Nucor Corporation
109 patents
- Progressive Inter…
Progressive International Corp.
109 patents
- Rittal & KG
Rittal GMBH & Co. KG
109 patents
- Shanghai Institut…
Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences
109 patents
- Neuravi ◀
Neuravi Limited
109 patents
What this shows Neuravi holds 109 patents at rank #3,402, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Neuravi
By rank, the assignees closest to #3,402 in granted patent volume.
- I.M.A. Industria Macchine Automatiche S.P.A. #3,398 · 109 patents
- IonQ, Inc. #3,399 · 109 patents
- Kerr Machine Co. #3,400 · 109 patents
- Mr. Bar-B-Q Products LLC #3,401 · 109 patents
- Nucor Corporation #3,403 · 109 patents
- Progressive International Corp. #3,404 · 109 patents
- Rittal GMBH & Co. KG #3,405 · 109 patents
- Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences #3,406 · 109 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Neuravi's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Neuravi, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Neuravi ranks #174 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (49 here).
Similar claim depth
Nearest assignees by average claims per patent (16.3 here).
Neuravi's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 6 | 5.5% |
| 2017 | 2 | 1.8% |
| 2018 | 2 | 1.8% |
| 2019 | 13 | 11.9% |
| 2020 | 12 | 11.0% |
| 2021 | 5 | 4.6% |
| 2022 | 16 | 14.7% |
| 2023 | 15 | 13.8% |
| 2024 | 32 | 29.4% |
| 2025partial year | 6 | 5.5% |
Which technologies does Neuravi Limited patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Neuravi Limited's patent record in context - here's where to go next.
- Neuravi Limited's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 97.2% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #3,402 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Neuravi Limited against I.M.A. Industria Macchine Automatiche S.P.A., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 49.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.